Hutchison China Meditech Adr (sponsored) Stock News

The risks of investing in Chinese stocks are growing.

Three of the most major drugmakers with roots in China, Zai Lab Ltd (NASDAQ: ZLAB), BeiGene Ltd (NASDAQ: BGNE), and Hutchmed China Ltd (NASDAQ: HCM), have been flagged by the SEC for failing to

Shares of many U.S.-listed Chinese stocks tumbled Thursday after the Securities and Exchange Commission put out an update about foreign companies using accounting firms or branches that cannot be adeq

A 2020 law called the Holding Foreign Companies Accountable Act may be behind the sharp decline in a handful of U.S-traded Chinese stocks.

TSX Symbol: WJX TORONTO , March 7, 2022 /CNW/ - Wajax Corporation (" Wajax " or the " Corporation ") today announced its 2021 fourth quarter and annual results. (Dollars in millions, except per share data) Three Months Ended December 31 Year Ended December 31 2021 2020 2021 2020 CONSOLIDATED RESULTS Revenue $402.8 $381.0 $1,637.3 $1,422.6 Equipment sales $119.8 $145.0 $484.2 $471.4 Product support $102.8 $101.9 $437.6 $411.8 Industrial parts $108.7 $85.5 $438.1 $342.6 Engineered repair services $61.9 $40.5 $241.7 $164.2 Equipment rental $9.6 $8.1 $35.5 $32.6 Net earnings $8.0 $10.7 $53.2 $31.7 Basic earnings per share (1) $0.37 $0.53 $2.50 $1.58 Adjusted net earnings (2)(3) $7.0 $9.6 $51.5 $35.1 Adjusted basic earnings per share (1)(2)(3) $0.33 $0.48 $2.41 $1.75 In commenting on the Corporation''s results, Iggy Domagalski , President and Chief Executive Officer, stated "In 2021, Wajax delivered record revenue of $1.6 billion , representing a 15% increase over the prior year." He continued, "Despite the unpredictable COVID-19 pandemic and related supply chain issues, we generated cash flows from operating activities of $190 million during the year, and we saw our leverage ratio drop to 1.29 times at December 31, 2021 , its lowest level in a decade.

HUTCHMED (China) Limited (HCM) CEO Christian Hogg on Q4 2021 Results - Earnings Call Transcript

Hutchison China MediTech press release (HCM): FY GAAP EPS of -$0.25 beats by $1.54.Revenue of $356.1M (+56.2% Y/Y) beats by $17.33M.

HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., Feb. 07, 2022 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM: HCM; SEHK:13) will be announcing its final results for th

The City of Olathe, Kansas, is to deploy Workday solutions with the assistance of Avaap. The project is part of the ambitious Olathe 2040 strategic plan that aims to make the city future-ready. Avaap revealed that it would deploy Workday Financial Management, Workday Human Capital Management (HCM), and Workday Payroll. It will see the organisation deploy new payroll, time [] The post City of Olathe selects Avaap to deploy new Workday solutions appeared first on Enterprise Times .

Hutchmed (China) Ltd (AIM:HCM, NASDAQ:HCM, HKG:0013) has moved higher after the start of new trials for a treatment for lung cancer. The phase 3 trial involves Hutchmed's orphathy (savolitinib), an o

Zacks Investment Research downgraded shares of HUTCHMED (NASDAQ:HCM) from a buy rating to a hold rating in a research note published on Monday morning, Zacks.com reports. According to Zacks, Hutchison China MediTech Limited researches, develops, manufactures and sells pharmaceuticals and health-related consumer products. The Company offers drugs for oncology and autoimmune diseases treatment. Hutchison China []

Michelle Northey Brings Over Two Decades of Industry Expertise to Lead Product at SmartLinx and Support Mission to Transform the Way the Healthcare Industry Supports Employees and Delivers Care SmartLinx, a leading provider of cloud-based workforce management solutions for senior care, announces the appointment of Michelle Northey as Chief Product Officer. At SmartLinx, Ms. Northey will [] The post SmartLinx Taps HCM Veteran Michelle Northey to Drive Product Innovation for the Senior Care Industry appeared first on TecHR .

After an infusion of cash from COVID-19 treatments, many companies are on the lookout for acquisitions.

Hutchison China MediTech (HCM) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earn

HONG KONG and FLORHAM PARK, N.J., Sept. 29, 2021 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“ HUTCHMED ”) (Nasdaq/AIM: HCM; HKEX:13) today announces that, further to its announcement in March 2